第三项诉讼质疑爱荷华州药店法, 援引联邦先发制人和宪法对费用分摊规则和偿还问题的关注。 A third lawsuit challenges Iowa’s pharmacy law, citing federal preemption and constitutional concerns over cost-sharing rules and reimbursements.

第三项诉讼已经提出,对爱荷华州参议院第383号档案提出质疑,该档案是规范药店福利管理者的法律,OptumRx和保险公司声称这违反了联邦法律和《第一修正案》,限制费用分摊做法,规定提高独立药店的报销额。 A third lawsuit has been filed challenging Iowa’s Senate File 383, a law regulating pharmacy benefit managers, with OptumRx and insurers claiming it violates federal law and the First Amendment by restricting cost-sharing practices and mandating higher reimbursements for independent pharmacies. 该法律要求 PBM 使用全国平均购置成本并设定 10.68 美元的配药费，在联邦优先购买方面面临法律挑战，特别是在 ERISA 下，以及正当程序问题。 The law, which requires PBMs to use national average acquisition costs and sets a $10.68 dispensing fee, faces legal challenges over federal preemption, particularly under ERISA, and due process concerns. 先前的两起诉讼导致临时禁令阻止执行,保险专员的混合执行行动引发了这一新案件。 Two prior lawsuits led to temporary injunctions blocking enforcement, and the insurance commissioner’s mixed enforcement actions prompted this new case. 原告试图阻止该法的实施,警告消费者和保险人费用大幅上涨,而支持者则认为该法有助于控制药品价格和支持小型药店。 Plaintiffs seek to halt the law’s implementation, warning of significant cost increases for consumers and insurers, while supporters argue it helps control drug prices and supports small pharmacies. 此案仍悬而未决。 The case remains pending.